Payment overview · 2025
General Payments
$68.42
4 reported records · 3 companies
Healthcare provider profile · identity verified
Richard Rivers, MD
Allopathic & Osteopathic Physicians|Family Medicine · ENID, OK · NPI 1609965136
Verified facts
What the public records show
CMS Open Payments records show Richard Rivers, MD received $68.42 in general payments during 2025 across 4 reported records.
Exact Sciences Corporation accounted for 54.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 8 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Mounjaro.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 128 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 101 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 114 claims for Trulicity by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $37.13 | 54.3% | 2 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $16.01 | 23.4% | 1 | 2025 |
| Merck Sharp & Dohme LLC | Unresolved — no canonical attribution shown | $15.28 | 22.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $68.42 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $37.13 | 2 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $16.01 | 1 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $16.01 | 1 | 2025 |
Source payment records
|
|||||
| CAPVAXIVE Normalized: capvaxive |
Biological | Merck Sharp & Dohme LLC | $15.28 | 1 | 2025 |
Source payment records
|
|||||
| GARDASIL 9 Normalized: gardasil 9 |
Biological | Merck Sharp & Dohme LLC | $15.28 | 1 | 2025 |
Source payment records
|
|||||
| M-M-R II Normalized: m m r ii |
Biological | Merck Sharp & Dohme LLC | $15.28 | 1 | 2025 |
Source payment records
|
|||||
| ROTATEQ Normalized: rotateq |
Biological | Merck Sharp & Dohme LLC | $15.28 | 1 | 2025 |
Source payment records
|
|||||
| VAXNEUVANCE Normalized: vaxneuvance |
Biological | Merck Sharp & Dohme LLC | $15.28 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| MOUNJARO mounjaro |
2025 | Mounjaro | 2024 | 101 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
128 | 23 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
101 | 17 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
114 | 17 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 843 | 197 |
| Atorvastatin Calcium | Atorvastatin Calcium | 667 | 156 |
| Amlodipine Besylate | Amlodipine Besylate | 613 | 153 |
| Furosemide | Furosemide | 486 | 113 |
| Potassium Chloride | Potassium Chloride | 475 | 98 |
| Gabapentin | Gabapentin | 460 | 125 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 453 | 66 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 434 | 122 |
| Alprazolam | Alprazolam | 433 | 72 |
| Losartan Potassium | Losartan Potassium | 392 | 94 |
| Pantoprazole Sodium | Pantoprazole Sodium | 370 | 76 |
| Metformin Hcl | Metformin Hcl | 353 | 88 |
| Carvedilol | Carvedilol | 320 | 67 |
| Omeprazole | Omeprazole | 313 | 78 |
| Metoprolol Succinate | Metoprolol Succinate | 310 | 65 |
| Tramadol Hcl | Tramadol Hcl | 305 | 66 |
| Eliquis | Apixaban | 301 | 46 |
| Citalopram Hbr | Citalopram Hydrobromide | 278 | 71 |
| Tamsulosin Hcl | Tamsulosin Hcl | 276 | 63 |
| Hydrochlorothiazide | Hydrochlorothiazide | 239 | 56 |
| Temazepam | Temazepam | 237 | 41 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 221 | 54 |
| Lisinopril | Lisinopril | 219 | 55 |
| Simvastatin | Simvastatin | 206 | 54 |
| Allopurinol | Allopurinol | 191 | 55 |
| Metoprolol Tartrate | Metoprolol Tartrate | 189 | 38 |
| Azithromycin | Azithromycin | 184 | 143 |
| Clopidogrel | Clopidogrel Bisulfate | 182 | 43 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 182 | 24 |
| Cephalexin | Cephalexin | 177 | 130 |
| Meloxicam | Meloxicam | 172 | 43 |
| Duloxetine Hcl | Duloxetine Hcl | 162 | 34 |
| Methimazole | Methimazole | 156 | 42 |
| Trazodone Hcl | Trazodone Hcl | 156 | 32 |
| Glipizide | Glipizide | 154 | 34 |
| Montelukast Sodium | Montelukast Sodium | 151 | 44 |
| Fluticasone Propionate | Fluticasone Propionate | 148 | 45 |
| Glipizide Er | Glipizide | 147 | 29 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 146 | 38 |
| Escitalopram Oxalate | Escitalopram Oxalate | 138 | 29 |
| Jardiance | Empagliflozin | 128 | 23 |
| Sertraline Hcl | Sertraline Hcl | 122 | 27 |
| Zolpidem Tartrate | Zolpidem Tartrate | 120 | 26 |
| Trulicity | Dulaglutide | 114 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 114 | 23 |
| Famotidine | Famotidine | 112 | 30 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 109 | 42 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 105 | 32 |
| Buspirone Hcl | Buspirone Hcl | 103 | 28 |
| Hydralazine Hcl | Hydralazine Hcl | 101 | 21 |
| Mounjaro | Tirzepatide | 101 | 17 |
| Ropinirole Hcl | Ropinirole Hcl | 101 | 26 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 98 | 58 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 96 | 75 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 95 | 22 |
| Pravastatin Sodium | Pravastatin Sodium | 86 | 19 |
| Doxazosin Mesylate | Doxazosin Mesylate | 85 | 19 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 83 | 21 |
| Xarelto | Rivaroxaban | 81 | 13 |
| Ibandronate Sodium | Ibandronate Sodium | 78 | 24 |
| Ozempic | Semaglutide | 78 | 18 |
| Pregabalin | Pregabalin | 78 | 20 |
| Bupropion Hcl Sr | Bupropion Hcl | 75 | 14 |
| Ezetimibe | Ezetimibe | 74 | 21 |
| Quetiapine Fumarate | Quetiapine Fumarate | 74 | 16 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 71 | 18 |
| Ondansetron Odt | Ondansetron | 71 | 36 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 70 | 16 |
| Memantine Hcl | Memantine Hcl | 69 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 68 | 14 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 67 | 57 |
| Fluoxetine Hcl | Fluoxetine Hcl | 67 | 14 |
| Sucralfate | Sucralfate | 67 | 16 |
| Fluconazole | Fluconazole | 64 | 31 |
| Ibuprofen | Ibuprofen | 59 | 14 |
| Primidone | Primidone | 59 | 11 |
| Acyclovir | Acyclovir | 56 | 31 |
| Clonidine Hcl | Clonidine Hcl | 56 | suppressed |
| Finasteride | Finasteride | 56 | 13 |
| Spironolactone | Spironolactone | 56 | 15 |
| Glyburide | Glyburide | 54 | 15 |
| Januvia | Sitagliptin Phosphate | 54 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 53 | 15 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 51 | 11 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 50 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 49 | 11 |
| Lorazepam | Lorazepam | 48 | 15 |
| Celecoxib | Celecoxib | 47 | 11 |
| Estradiol | Estradiol | 47 | 13 |
| Warfarin Sodium | Warfarin Sodium | 47 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 45 | 22 |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 44 | 13 |
| Lovastatin | Lovastatin | 44 | 13 |
| Synthroid | Levothyroxine Sodium | 44 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 43 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 42 | suppressed |
| Gemfibrozil | Gemfibrozil | 42 | 11 |
| Tresiba Flextouch U-100 | Insulin Degludec | 42 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 40 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 40 | suppressed |
| Digoxin | Digoxin | 39 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 39 | suppressed |
| Torsemide | Torsemide | 39 | 14 |
| Meclizine Hcl | Meclizine Hcl | 38 | 14 |
| Entresto | Sacubitril/Valsartan | 37 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 37 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 36 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 36 | 16 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 35 | 11 |
| Amiodarone Hcl | Amiodarone Hcl | 34 | suppressed |
| Methylprednisolone | Methylprednisolone | 34 | 30 |
| Bupropion Hcl | Bupropion Hcl | 33 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 33 | 11 |
| Alendronate Sodium | Alendronate Sodium | 32 | suppressed |
| Clonazepam | Clonazepam | 32 | suppressed |
| Diazepam | Diazepam | 32 | suppressed |
| Jantoven | Warfarin Sodium | 31 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 31 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 31 | 17 |
| Dexlansoprazole Dr | Dexlansoprazole | 29 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 29 | suppressed |
| Prednisone | Prednisone | 29 | 17 |
| Propylthiouracil | Propylthiouracil | 29 | suppressed |
| Atenolol | Atenolol | 28 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 28 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 28 | suppressed |
| Amoxicillin | Amoxicillin | 27 | 21 |
| Nystatin | Nystatin | 27 | 16 |
| Azelastine Hcl | Azelastine Hcl | 26 | 11 |
| Farxiga | Dapagliflozin Propanediol | 26 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 25 | suppressed |
| Rytary | Carbidopa/Levodopa | 25 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 24 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 24 | suppressed |
| Fentanyl | Fentanyl | 24 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 24 | 12 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Carisoprodol | Carisoprodol | 23 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 23 | suppressed |
| Metolazone | Metolazone | 23 | suppressed |
| Bupropion Xl | Bupropion Hcl | 22 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 22 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 22 | suppressed |
| Bumetanide | Bumetanide | 21 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 21 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 21 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 21 | suppressed |
| Mupirocin | Mupirocin | 21 | 11 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 21 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 21 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 20 | 15 |
| Glyburide-Metformin Hcl | Glyburide/Metformin Hcl | 20 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 20 | suppressed |
| Levetiracetam | Levetiracetam | 20 | suppressed |
| Novolog Flexpen | Insulin Aspart | 20 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 19 | 11 |
| Cefuroxime | Cefuroxime Axetil | 18 | 13 |
| Dilt-Xr | Diltiazem Hcl | 18 | suppressed |
| Dutasteride | Dutasteride | 18 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 18 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 18 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 17 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Telmisartan | Telmisartan | 17 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 16 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 16 | suppressed |
| Lamotrigine | Lamotrigine | 16 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 16 | suppressed |
| Topiramate | Topiramate | 16 | suppressed |
| Zaleplon | Zaleplon | 16 | suppressed |
| Amantadine | Amantadine Hcl | 15 | suppressed |
| Baclofen | Baclofen | 15 | suppressed |
| Easy Comfort Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 15 | suppressed |
| Naproxen | Naproxen | 15 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 15 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Valsartan | Valsartan | 15 | suppressed |
| Metronidazole | Metronidazole | 14 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 14 | suppressed |
| Risperidone | Risperidone | 14 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 14 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 14 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 13 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 13 | suppressed |
| Hydrocortisone | Hydrocortisone | 13 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 13 | suppressed |
| Brilinta | Ticagrelor | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Exemestane | Exemestane | 12 | suppressed |
| Glimepiride | Glimepiride | 12 | suppressed |
| Mesalamine Dr | Mesalamine | 12 | suppressed |
| Nabumetone | Nabumetone | 12 | suppressed |
| Novolog | Insulin Aspart | 12 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 12 | suppressed |
| Tradjenta | Linagliptin | 12 | suppressed |
| Trueplus Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 12 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 11 | suppressed |
| Cholestyramine Light | Cholestyramine | 11 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Indapamide | Indapamide | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 11 | suppressed |
| Ranolazine Er | Ranolazine | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $68.42 · 4 records | Exact Sciences Corporation | CAPVAXIVE, GARDASIL 9, M-M-R II, MOUNJARO, ROTATEQ, The Cologuard Plus Collection Kit, VAXNEUVANCE, ZEPBOUND | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Mounjaro play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error